FDA Inspection 1102899 — Sangamo Therapeutics, Inc
The FDA completed an inspection of Sangamo Therapeutics, Inc on July 11, 2019 in Richmond, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 11, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Richmond, CA (United States)
Additional Details
Sponsor, Contract Research Organization